Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial
Max Miller, Maria Leonsson‐Zachrisson, Nicolás Guzmán, Hiddo J.L. Heerspink et al.
Citations
6 citations
Journal
Nephrology Dialysis Transplantation
Topics
Diabetes Treatment and Management
Field-Weighted Citation Impact (FWCI)
7.77
article
Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial
Max Miller, Maria Leonsson‐Zachrisson, Nicolás Guzmán, Hiddo J.L. Heerspink, Patrick Barry Mark, Anna L. Eriksson, Erika De Sousa‐Amorim, Yunyun Jiang
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
Nephrology Dialysis TransplantationVol. 40(12)
Institutions
University Medical Center Groningen (NL), AstraZeneca (Poland) (PL), AstraZeneca (Spain) (ES), Queen Elizabeth University Hospital (GB), University of Glasgow (GB)